On January 9th, 2015, Masahiro Nanjo reported on a theme “Study on Consideration of Advantageous Effect Based on Experimental Data Obtain After Filing” -as trigered by Bristol Myers Squibb Co. v. Teva Pharmaceuticals (Federal Circuit No. 2013-1306)-” for Working Group on “Further Research on Inventive Step”, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

On January 9th, 2015, Masahiro Nanjo reported on a theme “Study on Consideration of Advantageous Effect Based on Experimental Data Obtain After Filing” -as trigered by Bristol Myers Squibb Co. v. Teva Pharmaceuticals (Federal Circuit No. 2013-1306)-” for Working Group on “Further Research on Inventive Step”, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

Working Group on “Further Research on Inventive Step”, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

“Study on Consideration of Advantageous Effect Based on Experimental Data Obtain After Filing” -as trigered by Bristol Myers Squibb Co. v. Teva Pharmaceuticals (Federal Circuit No. 2013-1306)-”

Reporter : Masahiro Nanjo

Date: 2015.1.9 | Seminers

TEL	: 81-3-6447-0211
FAX	: 81-3-6447-0212

Related posts:

On April 26th, Masahiro Nanjo reported on ” Problems of our Patent Law in view of Inherency Doctrine in the US” for Working Group on Specification Endurable in Patent Enformecent, Central Research Institute of Intellectual Property, Japan Patent Attorneys Association.

On July 13th, 2015, Masahiro Nanjo gave a lecture on “Supreme Court Decision on Product-By-Process Claims and Future Practice” for Pharma & Biotech Patent Cases Research Group in Japan Patent Attorney Association.

On July 2nd, 2015, Masahiro Nanjo will gave a lecture on a theme “Various Aspects of Inventions Originating from Academic Sector in view of Patent” for a symposiums in the 31st Annual Meeting of Japan Society of Drug Delivery System.